Psychedelic Invest is excited to announce that we’ve added 7 new companies to the Psychedelic Invest Index – making us fully up to date on all recent … [Read More...] about January, 2021 Update: Psychedelic Index Adds 7 New Companies
Main Content
Analysis
Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind
“The standard of care in mental health is broken and has been for decades.” We were … [Read More...] about Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind
Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge
After gaining 54.66% in the month of November, the Psychedelic Invest Index had a much … [Read More...] about Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge
Tryp Therapeutics Goes Public; Here’s Everything You Need to Know
Tryp Therapeutics, a development-stage pharmaceutical company focused on psilocybin and … [Read More...] about Tryp Therapeutics Goes Public; Here’s Everything You Need to Know
A New Fund Dedicated to Psychedelic Investments Has Launched in the UK
A firm touting itself as “Britain's first psychedelic healthcare fund” has launched with … [Read More...] about A New Fund Dedicated to Psychedelic Investments Has Launched in the UK
atai Life Sciences Appoints New CFO and CMO in Preparation for IPO
Global biotech company atai Life Sciences, which is developing psychedelic compounds for … [Read More...] about atai Life Sciences Appoints New CFO and CMO in Preparation for IPO
Press
Mydecine Innovations Group Files Application to list to the NASDAQ
Quick Take: Mydecine Innovations Group announced that it has submitted a formal … [Read More...] about Mydecine Innovations Group Files Application to list to the NASDAQ
Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US
Quick Take: Field Trip Health Ltd. announced today the opening of their fifth location … [Read More...] about Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US
Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression
Quick Take: Champignon Brands Inc. Chairman and CEO Roger McIntyre today announced the … [Read More...] about Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression